Table 1.

Characteristics of participants in the study.

Characteristics	Total (n = 167)	AZD1222 (n = 60)	BNT162b2 (n = 55)	mRNA‐1273 (n = 52)
Sex (n, %)
Female	83 (49.7%)	37 (61.7%)	26 (47.3%)	20 (38.5%)
Male	84 (50.3%)	23 (38.3%)	29 (52.7%)	32 (61.5%)
Age in years (mean, range)	41.3 (35–48)	41.2 (38.5–43.9)	39.0 (36.4–41.6)	43.9 (40.9–46.8)
Interval between 1st and 2nd dose (median, IQR)	27 (21–28)	24 (21–28)	27 (21–28)	27 (24.3–28)
Interval between 2nd and 3rd dose (median, IQR)	130 (110–135)	125 (118–134.5)	130 (110–141)	131 (102.3–133)

Abbreviation: IQR, interquartile range.